60.46USD-2.98%Mkt Cap: 6.02B $P/E: —Today
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap6.02B $
Enterprise Value4.86B $
Revenue (TTM)0 $
Gross Profit-352.48M $
Net Income (TTM)-345.91M $
Revenue/Share0.0000 USD
Last Price60.46 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees358
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA98420N1050
Valuation
P/E (Trailing)—
P/E (Forward)-12.28
PEG—
EV/EBITDA-11.07
EV/Revenue—
P/SInfinity
P/B4.65
EPS (TTM)-4.55
EPS (Forward)-4.87
52W Range
61.230% of range64.93
52W High64.93 USD
52W Low61.23 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-4612.13%
ROE-59.46%
ROA-54.63%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-279.12M $
CapEx (TTM)799.00K $
FCF Margin—
FCF Yield-3.38%
Net Debt-924.27M $
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity0.01
Current Ratio21.02
Quick Ratio20.71
Book Value/Sh12.84 USD
Cash/Share9.611 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)81.30 USD
Upside (mean)+34.5%
Target Range69.00 USD – 100.00 USD
$69.00+34.5% to mean$100.00
# Analysts19
Ownership
Shares Out.96.84M
Float90.95M
Insiders0.11%
Institutions108.16%
Short Interest
Short Ratio4.4d
Short % Float5.58%
Short % Out.5.57%
Shares Short5.38M
Short (prev mo.)6.26M
Technical
SMA 5061.94 (-2.4%)
SMA 20051.62 (+17.1%)
Beta0.63
S&P 52W Chg18.16%
Avg Vol (30d)611.97K
Avg Vol (10d)688.33K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—